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The cyclic structure of ADTC5 (Ac-CDTPPVC-NH2) peptide is known to have the ability to modulate homodimer 
E-cadherin interactions to form junction at the intercellular junction. Its function to inhibit E-cadherin interaction 
has become important to increase paracellular porosity in delivering drug molecules to the target cell. There are two 
types of ADTC5 state: opened-cyclic state (OCS) and closed-cyclic state (CCS). OCS of ADTC5 is affected by 
distance constraints, and CCS is formed by disulfide bond from terminal cysteines through force restraint. The 
purpose of this research is to determine the inhibition activity of ADTC5 peptide upon E-cadherin. Here we used 
molecular docking, and molecular dynamics approaches. The PyMOL program was generated by the structure of 
ADTC5 peptide. GROMACS v4.5.5 was utilized to simulate molecular dynamics. The ADTC5 peptide molecule 
was placed optimum in aqueous or polar condition at physiological pH. Furthermore, ADTC5 was docked with 
EC1-EC2 coupled domain of E-cadherin using AutoDock 4.2 and refined using molecular dynamic (MD). The result 
showed that CCS ADTC5 peptide has a stronger affinity and more stable interaction with EC1-EC2 coupled domain 
than the OCS one. 
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INTRODUCTION 
Delivering drugs into the brain tissue is blocked by 
the presence of biological barricades, called the blood-
brain barrier (BBB) in the paracellular pathway [1, 2]. 
The paracellular pathway consists of proteins barrier at 
the zonula occludens (tight junctions), zonula adherens, 
and desmosomes (gap junctions) [3]. These proteins se-
lectively allow the molecules with a diameter only below 
11 Å and the molecular weight below 500 Dalton [4] 
which can pass through the paracellular pathway [5]. 
The porosity of paracellular pathway can be ad-
justed by modulating homodimer E-cadherin interaction 
in the zonula adherens area at BBB [3]. The ADTC5 
peptide is derived from the bulge region on the EC1 do-
main. This peptide has the biological activity to enhance 
the porosity of paracellular pathway [6]. The ADTC5 
peptide has the ability to modify the BBB in the delivery 
of marker molecules such as, 14C-mannitol, gadolinium 
-diethylenetriaminepentacetate (Gd-DTPA)] to the 
brain over the paracellular pathways of the BBB. In vitro 
studies indicated that the ADTC5 had the best profile to 
inhibit junction resealing in Madin-Darby canine kidney 
cell monolayers. Furthermore, the ADTC5 peptide 
could increase in vivo delivery of Gd-DTPA to the brain 
of Balb/c mice when administered intravenously. There-
fore, the ADTC5 has potential to improve delivery of 
diagnostic and therapeutic agents to the brain [7]. 
According to the previous studies, the increasing  
porosity  by  the  ADTC5   peptides predicted by form-
ing a complex with five repeated extracellular domains 
(EC1, EC2, EC3, EC4, EC5) of E-cadherin [8, 9]. The 
study of interaction between peptide ADTC5 with E- 
cadherin can determine this complex formation. 
Knowledge of the molecular interactions will provide an 
understanding of the structure and eventually will be 
able to predict the function and properties of  biomole- 
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Table 1.  Generated OCS and CCS forms of the ADTC5 peptide 
by molecular dynamics approach 
Code OCS 
 Distance constraint 
of S14---S95 (nm) 
Force restraint 
(kJ.mol-1.nm-2) 
A1 All bond freely rotatable 
 
A2 0.3-0.4 None 
A3 0.3-0.4 4,000 
A4 0.3-0.4 12,000 
A5 0.2-0.3 None 
A6 0.2-0.3 4,000 
A7 0.2-0.3 12,000 
CCS 
B1 All bond freely rotatable A 
B2 None 4,000 
B3 None 12,000 
 
Table 2. The total number of water and ion molecules in each 
simulation system 
No. Code Total water Total ion 
Type of ion 
Na+ Cl- 
1. A1 1,692 10 5 5 
2. A2 1,691 10 5 5 
3. A3 N/A* N/A N/A N/A 
4. A4 1,691 10 5 5 
5. A5 1,692 10 5 5 
6. A6 N/A N/A N/A N/A 
7. A7 1,692 10 5 5 
8. B1 1,306 8 4 4 
9. B2 1,306 8 4 4 
10. B3 1,306 8 4 4 
*N/A = Not Available 
 
Table 3. The total number and Periodic Boundary Condition 
(PBC) size 
No. Code 
Total Atom  
(unit) 
PBC size (nm) 
1. A1 5,188 3.76329 × 3.76329 × 3.76329 
2. A2 5,188 3.92033 × 3.92033 × 3.92033 
3. A3 N/A* N/A 
4. A4 5,184 3.74830 × 3.74830 × 3.74830 
5. A5 5,188 3.75078 × 3.75078 × 3.75078 
6. A6 N/A N/A 
7. A7 5,188 3.72279 × 3.72279 × 3.72279 
8. B1 4,025 3.43038 × 3.43038 × 3.43038 
9. B2 4,025 3.43963 × 3.43963 × 3.43963 
10. B3 4,025 3.42386 × 3.42386 × 3.42386 
*N/A = Not Available 
cules [10]. Moreover, study the chemical structure mod-
ifications of peptide molecule can be done to increase its 
biological activity. This peptide structure involve linear 
and cyclic forms, S--S distance from start-end terminus 
amino acid on each Cysteine, and force restraint. They 
will affect to change ADTC5 structure conformation 
which causes the changes of binding site location upon 
EC1-EC2 coupled domain. Meanwhile, an understand-
ing of non-covalent bonds is required to learn the most 
favorable molecular interaction [11]. 
In this work, we mainly focused on the chemical 
stability features which can differentiate the CCS from 
OCS form of the ADTC5 peptide. Moreover, we focused 
on the description of CCS and OCS molecules in the 
microscopic behavior of physical systems, such as solva-
tion system using ion and water molecules, minimiza-
tion energy, constrained and unconstrained systems. 
The aim of this research is to determine the ADTC5 sta-
bility and binding affinity of the ADTC5 peptide with 
E-cadherin’s EC1-EC2 coupled domain. 
The hypothesis feature was generated and per-
formed as comparison between OCS and CCS models 
of the ADTC5. In this research, protein target of EC1-
EC2 coupled domain was used to find the best binding 
mode feature of OCS and CCS. To evaluate their stabil-
ity and interactions, computational aided-molecular dy-
namics simulations were carried out to generate 3D 
structures of OCS and CCS of the ADTC5 peptides. 
Molecular docking method was utilized to determine the 
interaction between OCS and CCS of the ADTC5 with 
EC1-EC2 coupled domain of E-cadherin protein. 
 
MATERIALS AND METHODS 
Protein and ligand preparation 
The EC1-EC2 coupled domain of E-cadherin struc-
ture was retrieved from Protein Data Bank (PDB ID No. 
2O72). While the PyMOL program was used to generate 
the structure of the ADTC5 peptide. Furthermore, this 
peptide molecule was simulated by molecular dynamics 
on GROMACS v4.5.5 [12-15]. Therefore, molecular dy-
namics was used to obtain the optimized structure in a 
different fashion, OCS, and CCS of ADTC5 peptide.  In 
preparation of ADTC5 states, sulphuric atoms within 
Cys1 and Cys6 residues consist of S14 and S95, respec-
tively, and these were arranged in several different force 
restraints and distance constraints as shown in Table 1. 
 
Molecular dynamics of the ADTC5 peptide with EC1-
EC2 domain of E-cadherin 
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Molecular dynamics were conducted in three steps:  
(1) System preparation. This aims is to prepare ADTC5 
structure and solvation system using energy minimiza-
tion and position restraint, respectively. This solvation 
system uses a simple cubical periodic box (the dimen-
sions of the box based upon setting the box edge ap-
proximately 1.0 nm from the molecule periphery), 
TIP3P (Transferable Intermolecular Potential 3-Point) 
water as a solvent, with ionic concentration is 0.15 M. 
The total number of water and ions in each simulation 
system are presented in Table 2. 
Trajectory generation was conducted with 120 ns 
(120,000 ps) running time. Analyzing trajectory by us-
ing total energy and RMSD (Root Mean Square Devia-
tion) of a Cα atom in every second ps [11]. The widely 
used CHARMM27 force field was implemented in the 
GROMACS simulation package [16]. The Berendsen 
weak-coupling algorithm was used in MD simulation 
which is extremely efficient to minimize the error in the 
ensemble scales during heating or equilibrium for relax-
ing the system to the targeted temperature [17]. The to-
tal number of atoms present in each simulation system 
and the size of the Periodic Boundary Cell (PBC) were 
specified in Table 2 and 3. 
Energy minimization was given after ions addition 
during MD simulation. It aims to decrease the excessive 
forces on peptide systems, such as dihedral tension and 
tight non-binding contact. These appear due to the ad-
dition of water molecules and ions in the simulation box, 
thus cause overlapping within some water molecules and 
ions, and it might produce high repulsion energy due to 
unstable interactions.  
 
Molecular docking of the ADTC5 peptide with EC1-EC2 
domain of E-cadherin 
Molecular docking was run by using Autodock v.4.2 
[18, 19] that involves two main parameters: Autogrid 
and Autodock. Autogrid is a grid box placed at: (1) 
Ala43, Asp44, Thr45 residues of the EC1 domain with 
all CCS variations (B1, B2, B3) as depicted at Figure 1 
and 2. The entire surface of EC1-EC2 coupled domain, 
using 11 boxes with one type of CCS (B1). The size of 
the box is 50 × 50 × 50 (125,000 grid points) with grid 
spacing set at 0.375 Å (Figure 2).  For all working types, 
the populations towards the genetic algorithm (GA) was 
150, a maximum number of evals was 5 × 106, a maxi-
mum number of generations was 27 × 103, and the num-
ber of genetic algorithms (GA) was 150. 
Autodock involved two stages: sampling and scor-
ing which used Lamarckian genetic algorithm and  
Figure 1. A gridbox position of the box A with x = 28.053 y = 
4.926 z = 48.111 (Ala43, Asp44, Thr45 residues in EC1 
domain) 
 
Figure 2. Eleven grid boxes (box A to K) on the entire surface of 
E1-EC2 coupled domain 
 
Figure 3. The RMSD value of Cα atom in A4 of OCS form 




Figure 4. ADTC5 conformation in two different states: a) 
Opened-cyclic state, OCS and b) Closed-cyclic state, 
CCS 
Structural Stability of ADTC5 Peptide  
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scoring, respectively. All default parameters were used 
by Autodock program. All the hydrogen added to the 
polar atoms on the peptides as the ligands and EC1-EC2 
coupled domain as the receptor. The charge type used 
was Gasteiger. After running Autodock, the data was 
grouped into one population based on similarity of 
RMSD < 2Å, to get the best binding mode [20]. The 
active site locations of EC1-EC2 macromolecules were 
determined by lower energy optimization, hydrogen 
bonds, van der Waals forces, and hydrophobic interac-
tion analysis.  
 
RESULTS AND DISCUSSION 
The 3D structures of the ADTC5 peptide were suc-
cessfully generated by Pymol program which first built 
structure as OCS with different energy optimization 
based on modified OCS arrangements (Table 4). To ob-
tain its cyclic conformation, the molecular dynamics 
simulation was conducted to find the best-optimized 
structure of CCS which mimics to native form (Table 
5).   
Molecular dynamics simulation at 120 ns (120,000 
ps) was run to obtain the optimized OCS and CCS 
forms. Based on OCS result, variations of molecular dy-
namics simulation were conducted by two different re-
arrangement conditions of S14—S95 atom interactions: 
distance constraint and force restraint. By arranging 
S14—S95 distances, it showed that the longer distance 
A5 and shorter distance (A1, A4, A7) of S14---S95 re-
sulted from the different energy optimizations due to re-
arranged-force constraints. The region of the ADTC5 
peptide was restrained during minimization is atom S14 
from the start-terminus amino acid of Cysteine and 
atom S95 from end-terminus of Cysteine. It was as-
sumed that the closer S14---S95 distance would give 
more stable OCS form based on the energy optimiza-
tions. Thus, A6 A4 showed the lowest energy optimiza-
tion compared to others -60,622 kJ/mol). However, the 
RMSD values from all OCS forms are still over 2 Å. 
Therefore, these OCS forms are still unstable and it sug-
gests that the presence of other non-covalent interac-
tions are needed to stabilize these structures, such as the 
amino acid side-chain interactions between the EC1-
EC2 coupled domain with the ADTC5 peptide.  
The A4 structure of OCS form was selected for fur 
further analysis. It did not form the cyclization. There-
fore, the sulfide bond addition to S14 and S95 atoms 
should be arranged manually. Moreover, by retaining 
force restraint of A4 structure of OCS form at 12,000 
kJ.mol-1.nm-2 upon both atoms, it showed that A4 struc-
ture has the best OCS form with S14---S95 distance at 
3.731 Å through molecular dynamics simulation (Figure 
4a). 
The CCS form with molecular dynamics simulation  
showed that in giving two different force restraint (4,000 
and 12,000 kJ.mol-1.nm-2) has resulted in similar energy 
optimization from B1, B2 and B3 forms (-47,044, -47,137 
and -47,095 kJ/mol, respectively) as shown in Table 5. 
The OCS form of the ADTC5 peptide has a rigid cyclic 
structure (Figure 4b), which does not cause a change in 
molecular dynamics simulation. To mimic the native 
peptide structure of the ADTC5 peptide, CCS structure 
was generated. According to the average energy optimi-
zation and S14---S95 distance arrangements, it showed 
that CCS structure has higher energy optimization than 
OCS. Thus, CCS conformation is more favorable com-
pared to OCS conformation.  
Also, to obtain the lowest energy optimization, B2 
of CCS form has been chosen due to it has the most 
stable conformation (-47,137 kJ/mol) compared to A4 of 
OCS form (Figure 3). The low RMSD value has shown 
B2 structure is stable in molecular dynamics simulation. 
Thus, CCS is very stable from the initial to the final 
molecular dynamics process (RMSD ± 0.05 nm), while 
OCS is unstable (RMSD ± 0.15 nm). Moreover, CCS 
structures were further investigated in the way how they 
bind to EC1-EC2 coupled domain. 
 
Molecular docking peptide ADTC5 with EC1-EC2 cou-
pled domain 
CCS form of the ADTC5 peptide was predicted has 
the highest similarity with ADTC5 native structure. 
Thus, the interaction can represent a cyclic ADTC5 na-
tive interaction. Molecular dynamics results provide 
three conformations (B1, B2, and B3) in different energy 
optimizations. Furthermore, three CCS forms were 
docked with EC1-EC2 coupled domain. 
In molecular docking, the best  binding mode de-
pends on: (1) the lowest affinity energy between ligand 
and protein, which is obtained from B1 binding mode 
(affinity energy -21,686 kJ/mol); (2) The highest amount 
of stable structures in a population, which is obtained 
from B1 binding mode (population of 81 structures); 
and (3) Validation of re-docking methods, characterized 
by comparing RMSD < 2 Å [21-23], obtained from B1 
binding mode (re-docking up to 76%, better than B2 
and B3). The most common parameters used in molec-
ular docking is RMSD value with the ADTC5 peptide 
with the lowest affinity energy. 
The ADTC5 interaction with the EC1-EC2 involves  
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 11 boxes, where 11  boxes are on the  entire  EC1-EC2 Table 4. The best structure for optimization molecular dynamics of OCS form 
Code Energy optimization (kJ/mol) Distance of S14---S95 (Å) Time (ps) Duration Time of Simulation (ps) 
A1 -59,855 9.880 63,376 120,000 
A2 -60,352 19.001 69,258 120,000 
A3 N/A* N/A N/A N/A 
A4 -60,622 3.731 87,101 120,000 
A5 -59,983 15.668 86,417 120,000 
A6 N/A N/A N/A N/A 
A7 -60,268 8.170 86,417 120,000 
*N/A = Not Available 
 
Table 5.  The best structure of CCS form in molecular dynamics optimization 
Code Energy optimization (kJ/mol) Distance of S14---S95 (Å) Time (ps) Duration Time of Simulation (ps) 
B1 -47,044 2.029 85,453 120,000 
B2 -47,137 2.027 17,914 120,000 
B3 -47,095 2.029 730 120,000 
 








Residues involve in hydrophobic interactions 







D of EC1 
 
Arg55, Tyr36, Ile53, Ile52, Gly49, 







E of EC1 
 
Trp2, Gln23, Ile24, Met92, 
Lys25, Val3, Asn27, Ser26, Ile4 
B3 -12.726 1 I of EC2 Asp1, Trp2, Val3, Pro5 
 
 
Figure 5. The interaction of the ADTC5 peptide towards EC1 and EC2 coupled domain surfaces of  E-cadherin: a) The strong OCS 
binding mode toward EC2 domain surface; b) The strongest CCS binding mode toward EC1 domain surface; c) The 
stronger CCS binding mode toward EC1 domain surface 
Structural Stability of ADTC5 Peptide  
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coupled domain, where position of box A to G (except 
C) are within EC1 domain, while boxing H to K are 
within EC2 domain,  and  box  C placed  in the middle 
region between EC1 and EC2 domains which it contains 
calcium atoms. From molecular docking results, interac-
tions of the ADTC5 peptide occur within three binding 
sites of EC1-EC2 coupled domain, there are two sites 
within box D and box E of the EC1 domain, with affin-
ity energy -21.686 kJ/mol and -20.215 kJ/mol, respec-
tively.  The other site of docking interaction was also 
found within the box I of the EC1 domain, with affinity 
energy -12.726 kJ/mol (Table 6). Meanwhile, the best 
docking result of B1 was refined using Molecular Dy-
namics (data not shown).  
 
Prediction inhibition of interactions EC1-EC2------EC1-
EC2 with ADTC5 peptide 
Five repeated extracellular domains (EC1-E2-E3-E4-
EC5) of E-cadherin homophilic can interact with other 
E-cadherin to form cis- and trans-dimer. In the paracel-
lular pathway, E-cadherin interaction forms junction is 
trans-dimer interaction with other E-cadherin. Some 
studies showed that the interaction could involve the 
other domains. These interactions are formed in two 
ways: (1) the interaction of groove region from EC1a 
domain of E-cadherin to the other EC1b domain of E-
cadherin in the bulge region [6] and (2) interaction from 
adhesion hands that will bind to the binding pocket 
[24]. 
Molecular docking study of the ADTC5 peptide 
showed that the ADTC5 inhibition upon trans-dimer in-
teraction between EC1-EC2 extensively involved several 
types of chemical interactions, such as: (1) Van der 
Waals interaction with Ala43, Phe35 and Arg55 Asp44 
and Val48 residues in the bulge region of EC1 domain 
and inhibits this bulge region to interact with grooves 
region. Also, hydrophobic interaction with Glu54, Ile52, 
Ile53, Tyr36, Ile38, Ser37, Val 81 and hydrogen bond 
with Ala43 which is between the bulge-groove regions 
from the EC1 domain of E-cadherin will help to inhibit 
interactions trans dimer in the EC1 domain. (2) Van der 
Waals interactions with Ile4, Lys25, Asn27 and Gln23 
residues on adhesion arm region from EC1 domain of 
E-cadherin, as well as hydrophobic interactions with 
Trp2, Val3,Met92, Ile24, Ser26 on binding pocket region 
from EC1 domain of E-cadherin, thus the interaction at 
binding pocket-adhesion arm region on EC1 domain of 
E-cadherin will be hindered by ADTC5 peptide and hy-
drogen bonds are Gln23 and Trp2; (3) hydrophobic in-
teractions of Asp1, Trp2 and Pro3 residues; and (4) hy-
drogen bond interactions with Val3 in the Adhesive Arm 
of EC1 (Figure 5). These three binding sites would in-
hibit the formation of trans-dimer between EC1-EC2 
coupled domains on the adjacent cells. Thus the inter-
action on junction will be weaker, and the paracellular 
pathways will be widely opened. 
In finding the ΔG value, the ADTC5 peptide in 
three CCS forms (B1, B2, B3) have been re-docked over 
than 1000 scoring iterations. ΔG value for B1 is within 
the range -12.93 to -16.95 kJ/mol; B2 is within the range 
-11.13 to -16.28 kJ/mol; and B3 is within the range -
10.46 to -17.45 kJ/mol. On the other hand, the affinity 
of the ADTC5 peptide in inhibiting trans-dimer EC1-
EC2 also can be determined through inhibition constant 
values (Ki). The Ki value of B3 is found having the 
strongest affinity (0.88 mM at pose 124) compared to B1 
and B2 (Table 6). Meanwhile, Ki value was found using 
formula ΔG = RT ln Ki (where ΔG is Gibbs free energy 
(kJ.mol-1), R is ideal gas constant (8.314 J.mol-1.K-1), and 
Ki is inhibition constant (mM)). 
The ADTC5 peptide was re-oriented towards the 
surface when it interacts with EC1-EC2 coupled do-
main. This phenomenon can be seen by a B1 form of 
the ADTC5 that has the best optimization of energy 
when the molecular dynamics does not have a good in-
teraction energy. It is claimed that structure with the 
best optimization does not have to produce the best in-
teraction energy due to a re-orientation towards the tar-
get. The best affinity energy is a B3 form (affinity ener- 
gy is -17.45 kJ/mol) of the ADTC5 peptide analyzed 
with molecular docking at the entire surface of the EC1-
EC2 coupled domain (Table 5). The result obtained that 
 
Table 7. Molecular docking of ADTC5 peptide (B1-B3) with 
EC1-EC2 within gridbox A 
ADTC5 Pose ΔG (kJ/mol) Ki (mM) 
B1 
26 -16.95 1,08 
57 -16.36 1,36 
 73 -12.93 5,41 
 147 -13.56 4,22 
B2 
23 -11.13 11,14 
71 -11.59 9,25 
80 -14.85 2,48 
100 -16.28 1,42 
124 -14.60 2,78 
B3 
23 -11.72 8,93 
38 -10.46 14,78 
 124 -17.45 0,88 
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the entire interaction energy is spontaneous by giving 
negative value on the affinity energy.  Moreover, the 
presence hydrogen bonds, van der Waals forces, and hy-
drophobic interactions to stabilize the ADTC5 peptide 
interaction with the EC1-EC2 domain [25].  
The affinity property of the ADTC5 peptide will af-
fect the drug delivery that across the paracellular path-
ways. In delivering the drug to body and brain cells, the 
ADTC5 cyclic peptide will increase the porosity of para-
cellular pathway and allow the drug molecules to pass 
through it. However, the modulating of the paracellular 
pathway will need Ki value less than 100 µM [10]. It will 
increase the porosity of ADCT5 peptide and allow the 
drug goes to the target cell and through the paracellular 
pathway. This study will be very useful in designing 




Our study showed that CCS of the ADTC5 pep-
tide has more stable interactions with EC1 domain than 
the OCS one. Pre-experiment proved that ADTC5 
which mimics to the native structure is in cyclic confor-
mation, with optimization energy at -47,137 kJ/mol and 
it is very stable from initial to final molecular dynamics 
simulation process (RMSD ratio ± 0.5Å). Molecular 
docking study between the ADTC5 with EC1-EC2 cou-
pled domain showed the best binding mode to EC1 (Box 
D), EC1 (Box E), and  EC2 (Box I) with the affinity 
energy at -21.686 kJ/mol, -20.215 kJ/mol, and -12.726 
kJ/ mol, respectively. 
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